Shares of Geron Corporation (GERN) tumbled 5.30% in pre-market trading on Wednesday, following the release of its first quarter 2025 financial results. Despite beating analyst estimates on some key metrics, investors appeared to focus on the company's continued net loss and high operating expenses.
Geron reported a Q1 EPS of -$0.03, surpassing the IBES estimate of -$0.04. The company's operating income came in at -$16.704 million, also better than the estimated -$23.5 million. However, these improvements were overshadowed by a substantial net loss of $19.835 million for the quarter.
A major concern for investors seems to be Geron's high operating expenses, which reached $56.307 million in Q1. This significant spending, likely related to ongoing research and development efforts, appears to be weighing heavily on the company's financial performance and investor sentiment. The pre-market plunge suggests that market participants may be growing impatient with the company's path to profitability, despite its progress in narrowing losses compared to analyst expectations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.